Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Link opens in a new tab
Search content at Icahn School of Medicine at Mount Sinai
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Endobronchial miRNAs as biomarkers in lung cancer chemoprevention
Celine Mascaux
, William J. Feser
, Marina T. Lewis
, Anna E. Barón
, Christopher D. Coldren
, Daniel T. Merrick
, Timothy C. Kennedy
, John I. Eckelberger
, Leslie M. Rozeboom
, Wilbur A. Franklin
, John D. Minna
, Paul A. Bunn
, York E. Miller
, Robert L. Keith
, Fred R. Hirsch
Research output
:
Contribution to journal
›
Article
›
peer-review
16
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Endobronchial miRNAs as biomarkers in lung cancer chemoprevention'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Lung Cancer
100%
Histology
100%
MicroRNA
100%
Endobronchial
100%
Cancer Chemoprevention
100%
Iloprost
83%
Current Smokers
50%
MicroRNA-34a (miR-34a)
50%
Transbronchial Biopsy
33%
Placebo
33%
Prostacyclin
33%
Former Smokers
33%
High-risk Individuals
16%
Quantitative PCR
16%
Mouse Model
16%
Smoking Status
16%
Quantitative Biomarkers
16%
Differentially Expressed
16%
High-risk Subjects
16%
Placebo-controlled Study
16%
Prognostic Biomarker
16%
Formalin-fixed
16%
6-month Follow-up
16%
Randomized Phase II Trial
16%
Chemoprevention Trial
16%
Healthy Lung
16%
Treatment Status
16%
Lung Tissue
16%
Histological Response
16%
Intermediate Endpoint
16%
MiR-375
16%
Prostaglandin Analogs
16%
Medicine and Dentistry
Lung Cancer
100%
Biological Marker
100%
microRNA
100%
Chemoprevention
100%
Histology
100%
Iloprost
83%
Placebo
33%
Prostacyclin
33%
Bronchus Biopsy
33%
Arm
16%
Chemoprophylaxis
16%
Placebo-Controlled Study
16%
Phase II Trials
16%
Real Time Polymerase Chain Reaction
16%
Biopsy Technique
16%
Prostacyclin Derivative
16%
microRNA 375
16%
Lung
16%
Oral
16%
Formaldehyde
16%